Icariin degrades mitochondrial DNA, reduces the protein expression of the PINK1–Parkin pathway, induces mitochondrial fragmentation, and acts synergistically with adriamycin to induce mitophagy and apoptosis to treat therapy-resistant hepatocellular carcinoma [29]. Here, PINK1 is linked to hepatocellular carcinoma.